Moreover, downregulation of p62 reduces IL-8 levels and increases CRC cell sensitivity to 5-fluorouracil (5-FU) and oxaliplatin (OxaPt), indicating its prognostic value as a predictor of treatment response [176]. The gene discussed is CXCL8; the disease is colorectal carcinoma.